Delivery Order SPE2DB22D2007-SPE2DB25FJ3HW
Award Date 7/25/25
Potential Completion Date 7/28/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,718.16 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count units). This firm fixed-price delivery order, awarded on July 31, 2025, represents a non-set-aside competitive procurement with an ultimate completion date of August 1, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count) valued at $1,412.73, with an ultimate completion date of June 5, 2025. This competitively awarded, non-set-aside delivery order employs firm fixed price terms and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count units) with a ceiling value of $15,577.90. This firm fixed-price delivery order, with an ultimate completion date of April 22, 2025, represents a non-set-aside competitive award executed under DLA's broader pharmaceutical supply chain. The place of performance is identified as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,849.59 to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (180-count package). This firm fixed-price delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, and represents a non-competitive set-aside procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,695.65 on September 10, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion deadline of September 11, 2025. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance. This delivery order represents a continuation of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,622.82 to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count packages). This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The order is scheduled for ultimate completion by June 18, 2025, with performance to be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,922.93 to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (180 count) on May 20, 2025, with an ultimate completion date of May 21, 2025. This firm fixed price delivery order, issued without a set-aside designation, represents a competitive award under the company's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,188.82 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count units) on July 25, 2025, with completion scheduled for July 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and represents a continuation of pharmaceutical procurement through DLA's existing contract vehicle. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $13,281.85 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180 count) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed price delivery order represents a non-competitive set-aside procurement and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,532.48 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180 count) on August 29, 2025. This firm fixed-price, competitively awarded contract is scheduled for completion by September 2, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a continuation of AmerisourceBergen's...